AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,768,000 | -59.9% | 306,872 | -52.3% | 1.38% | -73.5% |
| Q4 2017 | $24,342,000 | +26.4% | 643,626 | -17.1% | 5.21% | +34.0% |
| Q3 2017 | $19,257,000 | +20.6% | 776,813 | 0.0% | 3.89% | -3.2% |
| Q2 2017 | $15,971,000 | -3.7% | 776,813 | +1.8% | 4.02% | -17.5% |
| Q1 2017 | $16,580,000 | +6.3% | 763,009 | 0.0% | 4.88% | -5.2% |
| Q4 2016 | $15,604,000 | +36.3% | 763,009 | 0.0% | 5.14% | +44.2% |
| Q3 2016 | $11,445,000 | +38.6% | 763,009 | 0.0% | 3.57% | +58.2% |
| Q2 2016 | $8,256,000 | – | 763,009 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|